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ABSTRACT: 
Cells are physiologically ready to accumulate lipids such as triacylglycerides in the cytoplasm. 
Five classes of perilipin (PLIN) family proteins are known to be involved in the process of 
intracellular  lipid  accumulation.  PLIN2  is  expressed  ubiquitously  including  adipocytes, 
hepatocytes and macrophages. Over-expression of PLIN2 is demonstrated in the lesions of 
fatty  liver  diseases  and  atherosclerosis.  Suppression  of  PLIN2  expression  prevents  from 
developing these pathological conditions in animal models, suggesting that PLIN2 could be a 
therapeutic  target  molecule  for  excessive  intracellular  lipid  accumulation  which  leads  to 
various metabolic derangements.  The PLIN2 gene promoter has  two important cis-acting 
elements in close proximity:AP-1 element which mediates inflammatory signals and PPRE 
which mediates free fatty acid effect. In NMuLi mouse liver cells, FFA such as oleic acid 
requires both functional AP-1 and PPRE simultaneously to stimulate the promoter activity, 
indicating the presence of intimate interaction of inflammatory and metabolic signals on this 
gene. Pycnogenol
R, French maritime pine bark extracts, suppressed the oleic acid-induced 
PLIN2 expression and lipid accumulation in NMuLi cells. We found that Pycnogenol
R did not 
suppress  the  PLIN2  promoter  activity  or  AP-1  binding  to  DNA.  Instead,  Pycnogenol
R 
facilitates the PLIN2 mRNA degradation, leading to suppression of lipid accumulation. This 
effect seems to be independent of antioxidant effect of Pycnogenol
R. We raise the idea that 
PLIN2  is  a  putative  target  molecule  for  prevention  of  pathological  condition  induced  by Functional Foods in Health and Disease 2013; 3(9):353-364                                Page 354 of 364 
 
 
excessive lipid accumulation, and this class of natural compounds could be putative therapeutic 
modalities. 
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INTRODUCTION: 
Most types of cells accumulate lipids in the cytoplasm in a form of lipid droplets, because 
lipids are indispensable for living cells or organisms. Intracellular lipid droplets are energy 
storage in adipocytes. Lipid droplets provide materials for production of steroid hormones and 
eicosanoids as well. Lipids are components of cell membranes, transferred to whole body in a 
form of lipoprotein, and excreted as milk [1]. To date, five structurally related proteins are 
known to be involved in lipid droplet formation in the cells [2, 3]. These are called perilipin 
family proteins: perilipin (PLIN)1 (perilipin), PLIN2 (ADRP or adipophilin), PLIN3 (Tip47), 
PLIN4 (S3-12) and PLIN5 (OXPAT or MLDP) [4]. PLIN2 was identified adipocyte precursor 
cells  during  the  process  of  adipocyte  maturation,  thus  originally  named  adipose 
differentiation-related  protein  (ADRP)  [5].  Among  these  5  classes  of  proteins,  PLIN2  is 
ubiquitously expressed, not only in adipocytes but also other cell types including hepatocytes, 
macrophages and so on [6].  
Fig.1    PLIN2 is  a lipid droplet-associated protein.  GFP-labeled PLIN2 (ADRP) was forcedly 
expressed in Swiss 3T3 cells. PLIN2 (ADRP) promotes intracellular lipid accumulation. A representative single 
cell is shown. Oil-red O staining shows the lipid droplets in the cytoplasm. GFP-labeled PLIN2 locates on the 
surface of lipid droplets. (Modified from ref. 8, with permission). 
 
Physiological function of PLIN2 has not been fully elucidated as yet. PLIN2 stimulates 
uptake of long chain fatty acids [7]. We and others showed that forced expression of PLIN2 
promotes lipid accumulation and lipid droplet formation in fibroblasts [8] (Fig.1), hepatic 
stellate cells [9] and macrophages [10]. PLIN2 acts on lipid packaging in concert with PLIN3 
and PLIN4 [11]. We found that, in addition to PLIN2, PLIN3 is also specifically related to 
triacylglyceride (TAG) accumulation in macrophages [12, 13]. It has been proposed that fatty Functional Foods in Health and Disease 2013; 3(9):353-364                                Page 355 of 364 
 
 
acids, which are taken-up or de novo synthesized in the cells, are transported to endoplasmic 
reticulum (ER) lipid bilayer, and TAGs are synthesized and packaged [14]. PLIN2 is likely to 
be co-translated on the ER membrane in parallel with TAG synthesis. Thus, PLIN2 plays an 
important  role  for  TAG  accumulation  and  lipid  droplet  formation.  Whatever  the  precise 
mechanism is, organisms are always ready for energy storage as a form of TAG during excess 
of nutrients. Actually, PLIN2 protein is rapidly degraded through proteasomal pathway when 
lipids are not available [15, 16]. Organisms might have acquired “depository genes” like 
PLIN2 during the process of evolution in order to survive the starvation, which could maximize 
the function of “thrifty genes” [17].  
 
PLIN2  could  be  a  putatve  therapeutic  target  molecule:  Despite  the  physiological 
importance of lipid storage in cells, excessive or inappropriate lipid accumulation causes not 
only obesity but also various metabolic derangements. Increased expression of PLIN2 has been 
proved in these pathological conditions. In atherosclerotic lesions, high expression of PLIN2 
mRNA was demonstrated [18, 19]. Up-regulation of PLIN2 expression was observed in human 
fatty  liver  and  rodent  model  of  liver  steatosis  induced  by  high  fat  diet  [20]. 
Adenovirus-mediated PLIN2 transgenic mice developed fatty liver and increased TAG content 
in the liver (Sonoda N et al, unpublished observation). It was shown that increased expression 
of PLIN2 protein in skeletal muscle negatively correlates with insulin sensitivity [21], although 
the opposite finding was also reported [22]. 
On the other hand, a number of reports demonstrated that reduced or deficient expression 
of  PLIN2  decreases  intracellular  lipid  accumulation,  leading  to  amelioration  of  these 
pathological conditions in animal models. Genetic ablation of the PLIN2 gene reduced the 
number of lipid droplets in foam cells in atherosclerotic lesions in ApoE
-/- mice and protected 
the mice against atherosclerosis [23]. PLIN2
-/- mice showed reduced hepatic TAG content and 
were  protected  against  fatty  liver  formation  [24,  25].  Antisense  oligonucleotide-mediated 
reduction of PLIN2 in the liver also ameliorated hepatic steatosis, hypertriglyceridemia and 
insulin resistance in Lep
ob/ob as well as diet-induced obese mice [26]. 
Taken together, all these results indicate that PLIN2 plays a significant role not only in 
physiological but also in pathological accumulation of intracellular lipids. And these findings 
implicate that PLIN2 could be a possible therapeutic target molecule. Thus, the reduction of 
PLIN2 expression could be effective for treatment or prevention of conditions induced by 
excessive intracellular lipid accumulation such as fatty liver disease or atherosclerosis. Based 
on this presumption, we have been searching for putative synthetic or natural compounds 
which suppress the PLIN2 expression, and been finding out the mechanism of the action. Functional Foods in Health and Disease 2013; 3(9):353-364                                Page 356 of 364 
 
 
 
Regulatory  mechanism  of  the  PLIN2  gene  by  free  fatty  acids:  Inflammo-metabolic 
connection: It is necessary to disclose the regulatory mechanisms of PLIN2 gene expression in 
order to achieve our purposes. Long-chain, but not short-chain, free fatty acids such as oleic 
acid effectively stimulate the expression of PLIN2 mRNA and its protein in NMuLi mouse 
liver cells (Fig.5A) [27]. We have characterized a 2.8kb region of the mouse PLIN2 gene 
promoter and identified several important cis-acting elements for regulation of the gene [15, 
27].  
Fig.2    Inflammo-metabolic  connection.  Two  important  cis-acting  elements,  Ets/AP-1  composite 
element and PPAR-response element (PPRE), are located in close proximity, both in mouse and human PLIN2 
gene promoter.  AP-1 mediates inflammatory signals. PPRE mediates the effects of specific chemical PPAR 
ligands, while the effect of long-chain free fatty acids is mediated both by AP-1 and PPRE. This surmise is proved 
in Fig.3 and Fig.4. 
 
We, as well as others, identified a peroxisome proliferator-activated receptor (PPAR) 
response element (PPRE), which responds to specific PPAR ligands as well as long-chain fatty 
acids, at 2kb up-stream of the transcriptional start site [15, 28]. Additionally, we identified an 
Ets/AP-1 composite element, which is located closely to the PPRE on its upstream (Fig.2). It is 
well known that  AP-1  proteins  are representative mediators of inflammatory  stimulation. 
Sequence of the region encompassing these elements is well conserved between mouse and 
human genes (Fig.2). Although we demonstrated  that transcription factors PU.1 and AP-1 
conjointly bind to the Ets/AP-1 composite element and exert the maximal promoter activation 
in macrophages [15], only AP-1 recognizes the element in NMuLi liver cells because this cell Functional Foods in Health and Disease 2013; 3(9):353-364                                Page 357 of 364 
 
 
line does not express PU.1 or other Ets family transcription factors [27].  
Fig. 3 Oleic acid requires both AP-1 and PPRE to stimulate the PLIN2 promoter activity. 
A) Schematic presentation of the PLIN2 promoter-driven luciferase constructs. X denotes the loss of function 
mutation artificially introduced.  B) Oleic acid-induced increase in the promoter activity was diminished by 
deletion of all three functional elements, PPRE mutation or AP-1 mutation. Ets mutation showed decreased basal 
promoter activity but was still responsive to oleic acid; (Modified from ref. 27, with permission). 
 
In  order  to  characterize  the  function  of  these  elements,  we  constructed  a  series  of 
promoter-luciferase constructs (Fig.3A) and assessed promoter activity. Oleic acid stimulated 
the activity of wild type promoter (-2090bp), while -1889bp promoter, which lacks all three 
elements, and PPRE-mutated promoter (Pmut) failed to respond to oleic acid as expected 
(Fig.3B). Interestingly, stimulatory effect of oleic acid also diminished in the AP-1 mutation 
(Amut) (Fig.3B). This mode of action of oleic acid is totally different from that of specific 
PPAR ligands. Thus, synthetic ligands for PPAR, , and  did stimulate the promoter activity 
of AP-1 mutation, while oleic acid did not (Fig.4). These results indicated that metabolic 
factors such as free fatty acids, activate PLIN2 expression through or in conjunction with an 
inflammatory mediator AP-1. We named this interaction as “inflammo-metabolic connection”, 
and PLIN2 is a target molecule of this connection. In addition to the function as a ligand for 
PPARs, long-chain fatty acid activates membrane receptors such as GPR40 and GPR120 (29, 
30). It was also reported that oleic acid activates AP-1 activity through ERK1/2 activation (31).  
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Fig. 4 Effect of specific PPAR ligands is mediated only by PPRE. Specific PPAR ligands, 
troglitazone (PPAR), GW501516 (PPAR) and fenofibrate(PPAR) could stimulate the AP-1-mutated promoter 
(Amut). Their stimulatory effects were only diminished in PPRE-mutated promoter (Pmut). Note that PPAR 
expression vector was co-transfected when tested the effect of PPAR ligand, because NMuLi cells do not express 
PPAR. These effects are totally different from oleic acid (OA) shown in the box. (Modified from ref. 27, with 
permission). 
 
Pycnogenol
R  suppresses  lipid  accumulation  by  facilitating  the  PLIN2  mRNA 
degradation in liver cells: We have been looking for putative compounds which suppress the 
PLIN2 expression. Although PLIN2 expression is suppressed by chemical compounds such as 
PI3  kinase  inhibitors  in  macrophages  (15)  and  NMuLi  cells  (Ikuyama  S  unpublished 
observation), this class of compounds is not suitable for clinical application. Therefore, we 
have been searching a candidate compound that fulfills our purpose among natural products. 
We focused on Pycnogenol
R (kindly provided by Horphag Research, Geneva, Switzerland), 
which is an extract from the bark of French maritime pine and has been used as a historical 
medicinal material for the treatment of scurvy, skin wound and sores (32). Various beneficial 
effects of French maritime pine bark extract have been disclosed to date, including the effects 
on cardiovascular disorders, diabetes and so on, and the underlying biological mechanisms Functional Foods in Health and Disease 2013; 3(9):353-364                                Page 359 of 364 
 
 
have also been investigated (33). Pycnogenol
R is a mixture of phenols, polyphenols, taxifolin 
and condensed flavonoids, and has a strong anti-oxidant effect (34). The Anti-inflammatory 
effects of Pycnogenol
R, such as effects on TNF--induced or NFB-mediated gene expression, 
were also disclosed (35, 36). We expected that these biological properties were to be fit for 
suppression of PLIN2 expression considering the regulatory mechanism of the gene. 
 
Fig. 5 Pycnogenol
R suppresses the PLIN2 expression and intracellular lipid accumulation 
in NMuLi liver cells. A) Pycnogenol
R (PYC) suppressed oleic acid induced increase in the PLIN2 mRNA 
(upper panel) and protein (lower panel). B) Pycnogenol
R suppressed oleic acid-induced lipid accumulation (Oil 
red O staining); (Modified from ref. 27, with permission). 
 
As expected, we found that Pycnogenol
R suppressed oleic acid-induced PLIN2 mRNA 
expression in parallel with its protein level (Fig.5A). In concert with this effect, Pycnogenol
R 
suppressed  oleic  acid-induced  lipid  accumulation  in  NMuLi  cells  (Fig.5B).  Considering 
possible biological effects of Pycnogenol
R as mentioned above and functional importance of 
AP-1 in the PLIN2 promoter, we presumed that Pycnogenol
R would suppress the PLIN2 gene 
expression at the transcriptional level. In contrast to our presumption, Pycnogenol
R did not 
inhibit the PLIN2 promoter activity (27). In addition, AP-1 binding activity in nuclear extracts 
prepared from Pycnogenol
R-treated cells was also not reduced (27). These results suggested 
that  Pycnogenol
R  exerted  other  action  on  the  PLIN2  mRNA  expression.    Therefore,  we 
assessed a half-life of PLIN2 mRNA in the presence or absence of Pycnogenol
R. As shown in 
Fig. 6, the half-life of PLIN2 mRNA was significantly reduced in the presence of Pycnogenol
R; 
an estimated half-life was 6 hours in the presence of Pycnogenol
R while 11 hours in the absence 
of Pycnogenol
R. Thus, Pycnogenol
R facilitates the PLIN2 mRNA degradation, reduction in 
PLIN2 protein, thus leading to suppression of lipid accumulation in the cells.  Functional Foods in Health and Disease 2013; 3(9):353-364                                Page 360 of 364 
 
 
Fig. 6 Pycnogenol
R facilitates the PLIN2 mRNA degradation. PLIN2 mRNA level was assessed 
by Northern blot analysis (A) and Real-time PCR (B). (Modified from ref. 27, with permission). 
 
Although  dominant  biological  effects  of  Pycnogenol
R  have  been  attributed  to  its 
antioxidant  property  (34),  its  suppressive  effect  of  the  PLIN2  expression  could  not  be 
explained by the antioxidant action, and seems to be specific. Curcumin and astaxanthin, which 
are well-known antioxidant substances (37, 38), failed to suppress the oleic acid-stimulated 
PLIN2  mRNA  expression  (27).  In  addition,  DNA  binding  of  AP-1  and  NFb,  typical 
redox-sensitive transcription factors, was not inhibited by Pycnogenol
R (12, 27). We presume 
that Pycnogenol
R could modify the activity of probable stabilizing or destabilizing factors of 
the PLIN2 mRNA, although this surmise has not been proved. 
 
CONCLUSION: 
In this review, we described “depository genes” such as PLIN family proteins that act on the 
lipid  accumulation.  In  particular,  molecular  mechanism  of  the  PLIN2  expression  was 
elaborated based on the results of our investigation. And we raised the idea that PLIN2 could be 
a possible molecular target for prevention or therapy of the pathological conditions associated 
with excessive intracellular lipid accumulation, like fatty liver disease or atherosclerosis. In Functional Foods in Health and Disease 2013; 3(9):353-364                                Page 361 of 364 
 
 
this regard, the agents which suppress the PLIN2 expression should be guaranteed safety-wise. 
We have not yet found possible candidate chemical compounds which meet this purpose. 
Functional  food  like  Pycnogenol
R,  could  be  a  promising  natural  compound  although  the 
clinical usefulness should be strictly verified. 
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